Neuroscience Area

08/10/2020

Presented a program capable of automatically detecting neurodegeneration biomarkers through magnetic resonance imaging

05/10/2020

Researchers discover a new genetic disease of the nervous and cardiac systems

24/09/2020

Interferon, the key to many of the worst cases of COVID-19 in young people

31/08/2020

ADmit Therapeutics receives 3.3 million euros from the European Commission to bring its early diagnosis test for Alzheimer’s to the market

24/08/2020

Sleep eight hours benefit the retention of weaker memories

15/07/2020

Designed a new and user-friendly model to predict the life expectancy of a severe neurodegenerative disease

23/06/2020

IDIBELL involves citizens with the survey «Health in times of confinement due to coronavirus»

04/06/2020

Discovery of a new mechanism of homeostatic plasticity in autaptic neural connections

20/05/2020

Cells of the intestine nervous system and oligodendrocytes are affected in Parkinson’s disease

08/05/2020

ADmit Therapeutics obtains the support of the Alzheimer’s Drug Discovery Foundation (ADDF) to develop its early Alzheimer’s diagnostic test.

Scroll to Top